The disposition of LY518674, a new peroxisome proliferator-activated receptor-α agonist, in humans

被引：0
|
作者：
Farid, Nagy A. [1 ]
Smith, Richard L. [1 ]
Calvert, Nathan A. [1 ]
Annes, William F. [1 ]
Abu-Raddad, Eyas J. [1 ]
Long, Amanda J. [1 ]
机构：
[1] Eli Lilly & Co, Lilly Res Labs, Div Drug Disposit, Indianapolis, IN 46285 USA
来源：
DRUG METABOLISM REVIEWS | 2006年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
126
引用
收藏
页码：77 / 78
页数：2
相关论文
共 50 条
  • [21] Regulation of adiponectin receptors in hepatocytes by the peroxisome proliferator-activated receptor-γ agonist rosiglitazone
    X. Sun
    R. Han
    Z. Wang
    Y. Chen
    Diabetologia, 2006, 49 : 1303 - 1310
  • [22] Potent peroxisome proliferator-activated receptor-α agonist treatment increases cholesterol efflux capacity in humans with the metabolic syndrome
    Khera, Amit V.
    Millar, John S.
    Ruotolo, Giacomo
    Wang, Ming-Dauh
    Rader, Daniel J.
    EUROPEAN HEART JOURNAL, 2015, 36 (43) : 3020 - 3022
  • [23] Expression of peroxisome proliferator-activated receptor-γ1 and peroxisome proliferator-activated receptor-γ2 in visceral and subcutaneous adipose tissue of obese women
    Giusti, V
    Verdumo, C
    Suter, M
    Gaillard, RC
    Burckhardt, P
    Pralong, F
    DIABETES, 2003, 52 (07) : 1673 - 1676
  • [24] Impact of peroxisome proliferator-activated receptor-α on diabetic cardiomyopathy
    Lin Wang
    Yin Cai
    Liguo Jian
    Chi Wai Cheung
    Liangqing Zhang
    Zhengyuan Xia
    Cardiovascular Diabetology, 20
  • [25] Peroxisome proliferator-activated receptor-γ is a new therapeutic target in sepsis and inflammation
    Zingarelli, B
    Cook, JA
    SHOCK, 2005, 23 (05): : 393 - 399
  • [26] Impact of peroxisome proliferator-activated receptor-α on diabetic cardiomyopathy
    Wang, Lin
    Cai, Yin
    Jian, Liguo
    Cheung, Chi Wai
    Zhang, Liangqing
    Xia, Zhengyuan
    CARDIOVASCULAR DIABETOLOGY, 2021, 20 (01)
  • [27] Emerging roles of peroxisome proliferator-activated receptor-β/δ in inflammation
    Bishop-Bailey, David
    Bystrom, Jonas
    PHARMACOLOGY & THERAPEUTICS, 2009, 124 (02) : 141 - 150
  • [28] Diclofenac antagonizes peroxisome proliferator-activated receptor-γ signaling
    Adamson, DJA
    Frew, D
    Tatoud, R
    Wolf, CR
    Palmer, CNA
    MOLECULAR PHARMACOLOGY, 2002, 61 (01) : 7 - 12
  • [29] Role of Peroxisome Proliferator-Activated Receptor-γ in Atherosclerosis - An Update
    Wang, Nanping
    Yin, Ruiying
    Liu, Yan
    Mao, Guangmei
    Xi, Fang
    CIRCULATION JOURNAL, 2011, 75 (03) : 528 - 535
  • [30] Regulation of peroxisome proliferator-activated receptor-γ in liver fibrosis
    Yang, Liu
    Chan, Che-Chang
    Kwon, Oh-Sang
    Liu, Songling
    McGhee, Jason
    Stimpson, Stephen A.
    Chen, Lihong Z.
    Harrington, W. Wallace
    Symonds, William T.
    Rockey, Don C.
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2006, 291 (05): : G902 - G911
12345